M675-1655 Screening compound: N-[(2-{1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-piperidyl}-1,3-thiazol-4-yl)methyl]-1-cyclobutanecarboxamide

M675-1655 Screening compound: N-[(2-{1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-piperidyl}-1,3-thiazol-4-yl)methyl]-1-cyclobutanecarboxamide
M675-1655 Screening compound: N-[(2-{1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-piperidyl}-1,3-thiazol-4-yl)methyl]-1-cyclobutanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M675-1655
N-[(2-{1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-piperidyl}-1,3-thiazol-4-yl)methyl]-1-cyclobutanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M675-1655

Molecular Formula

C19H27N5O3S2 (C19 H27 N5 O3 S2)

Compound Name

N-[(2-{1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-piperidyl}-1,3-thiazol-4-yl)methyl]-1-cyclobutanecarboxamide

IUPAC name

N-[(2-{1-[(35-dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl}-13-thiazol-4-yl)methyl]cyclobutanecarboxamide

SMILES

Cc([nH]nc1C)c1S(N(CC1)CCC1c1nc(CNC(C2CCC2)=O)cs1)(=O)=O

InChI

InChI=1S/C19H27N5O3S2/c1-12-17(13(2)23-22-12)29(26,27)24-8-6-15(7-9-24)19-21-16(11-28-19)10-20-18(25)14-4-3-5-14/h11,14-15H,3-10H2,1-2H3,(H,20,25)(H,22,23)

InChI Key

PYYBRMUEXMCAOW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27550721

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.115

Distribution Coefficient, logD

1.115

Water Solubility, LogSw

-1.95

Polar Surface Area

91.030

Acid Dissociation Constant (pKa)

6.78

Base Dissociation Constant (pKb)

1.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.16

M675-1655 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with M675-1655 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M675-1655?
Check Price and Availability of M675-1655, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M675-1655 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M675-1655
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M675-1655
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M675-1655 available by request